Evogene LTD. – Ordinary Shares (NASDAQ:EVGN) Sellers Reduced By 40.85% Their Shorts As Of Mar 15, 2019

Evogene Ltd. (NASDAQ:EVGN) Corporate Logo

Evogene LTD. – Ordinary Shares (NASDAQ:EVGN) recorded a decrease of 40.85% in short interest. FINRA issued in March EVGN’s total 13,900 short interest. The down change of 40.85% from 23,500 shares was reported. Former EVGN’s position will need 4 days to restore. It has 3,600 average volume. 0.06% is Evogene LTD. – Ordinary Shares float short.

EVGN is reaching $1.9399 during the last trading session, after increased 1.04%.Evogene Ltd. has volume of 1,239 shares. Since March 15, 2018 EVGN has declined 28.84% and is downtrending. EVGN underperformed the S&P500 by 33.21%.

Evogene Ltd., a biotechnology company, focuses on the enhancement of crop productivity and performance in the United States and Germany.The firm is valued at $49.61 million. It operates through two divisions, Evogene and Evofuel.Last it reported negative earnings. The Evogene segment develops seed traits, ag-chemical products, and ag-biological products to enhance plant performance.

For more Evogene Ltd. (NASDAQ:EVGN) news announced recently go to: Benzinga.com, Prnewswire.com, Globenewswire.com, Globenewswire.com or Cnbc.com. The titles are as follows: “This Day In Market History, March 13: Microsoft IPO (NASDAQ:MSFT) – Benzinga” announced on March 13, 2019, “Latest General Business News and Press Releases – PR Newswire” on October 14, 2017, “Evogene and IMAmt Enter a Collaboration in the Field of Insect Resistance Traits in Cotton – GlobeNewswire” with a publish date: July 17, 2018, “Evogene to Participate in Israeli Consortium to Develop Phenotyping Tools and Systems for Precision Agriculture – GlobeNewswire” and the last “5 tech trades on Nasdaq’s record close – CNBC” with publication date: July 17, 2015.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.